PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
19-Dec-2024 Nxera Pharma and Shionogi Launch QUVIVIQ™ in Japan for Adults with Insomnia Nxera Pharma
19-Dec-2024 Bioxodes meets enrollment milestone in Phase 2a intracerebral hemorrhagic stroke trial Bioxodes
19-Dec-2024 ACG Expands Global Footprint with New Capsule Manufacturing Facility in Thailand ACG
19-Dec-2024 Stryker honored with HIRC’s gold badge for resiliency Stryker
19-Dec-2024 ICON announces Appointment of Chief Operating Officer ICON
19-Dec-2024 Cantourage Group SE exports medical craft cannabis for the first time to the growth market of Poland; cooperation with the wholesaler PharmaVitae to be expanded in 2025 Cantourage Group SE
19-Dec-2024 DOUGLAS Group achieves strong results and strategic progress in financial year 2023/24 Douglas AG
19-Dec-2024 Xlife Sciences AG Publishes 2023 ESG Report: A Continued Commitment to Sustainable Innovation Xlife Sciences AG
18-Dec-2024 Mandy Deakin-Snell Joins NeX e-Commerce Logistics Hub as Head of Global Academy Program NeX e-Commerce
18-Dec-2024 Anaveon appoints Dr. Richard Sachse as Chief Medical Officer Anaveon
18-Dec-2024 Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH) MPH Health Care AG
18-Dec-2024 Trend-setting decontamination: SYNBIOTIC and GOC NEXUS set the gold standard for cannabis SYNBIOTIC SE
18-Dec-2024 ENA Respiratory Announces Peer-Reviewed Publication of First Time in Humans and Influenza Virus Challenge Studies with the Intranasal Innate Immunomodulator INNA-051 ENA Respiratory
18-Dec-2024 Johnson & Johnson submits application to the European Medicines Agency seeking approval of a new indication for IMBRUVICA® (ibrutinib) Johnson & Johnson
18-Dec-2024 New terbinafine supplier secured Moberg Pharma AB
18-Dec-2024 Original-Research: SYNBIOTIC SE (von NuWays AG) SYNBIOTIC SE
17-Dec-2024 TOPTICA Photonics Inc. Participates in Federally-Funded Quantum Project TOPTICA Photonics Inc.
17-Dec-2024 Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Sanofi
17-Dec-2024 EyeDNA Therapeutics Receives Rare Pediatric Disease Designation from FDA for its Investigational Gene Therapy HORA-PDE6b for Patients with Retinal Dystrophy due to PDE6b Gene Mutations EyeDNA Therapeutics
17-Dec-2024 Marinomed Biotech AG: Requirements for successful completion of the restructuring proceedings achieved Marinomed Biotech AG